Necrosis Links Neurodegeneration and Neuroinflammation in Neurodegenerative Disease

Int J Mol Sci. 2024 Mar 24;25(7):3636. doi: 10.3390/ijms25073636.

Abstract

The mechanisms of neuronal cell death in neurodegenerative disease remain incompletely understood, although recent studies have made significant advances. Apoptosis was previously considered to be the only mechanism of neuronal cell death in neurodegenerative diseases. However, recent findings have challenged this dogma, identifying new subtypes of necrotic neuronal cell death. The present review provides an updated summary of necrosis subtypes and discusses their potential roles in neurodegenerative cell death. Among numerous necrosis subtypes, including necroptosis, paraptosis, ferroptosis, and pyroptosis, transcriptional repression-induced atypical cell death (TRIAD) has been identified as a potential mechanism of neuronal cell death. TRIAD is induced by functional deficiency of TEAD-YAP and self-amplifies via the release of HMGB1. TRIAD is a feasible potential mechanism of neuronal cell death in Alzheimer's disease and other neurodegenerative diseases. In addition to induction of cell death, HMGB1 released during TRIAD activates brain inflammatory responses, which is a potential link between neurodegeneration and neuroinflammation.

Keywords: ALS; Alzheimer’s disease; FTLD; HMGB1; Huntington’s disease; Parkinson’s disease; TRIAD; YAP; apoptosis; ferroptosis; necroptosis; necrosis; paraptosis; pyroptosis.

Publication types

  • Review

MeSH terms

  • Cell Death
  • HMGB1 Protein*
  • Humans
  • Necrosis
  • Neurodegenerative Diseases*
  • Neuroinflammatory Diseases

Substances

  • HMGB1 Protein

Grants and funding

This research was funded by the Japanese Society for the Promotion of Science (JSPS) (16H02655, 19H01042, 22H00464), by Japan Agency for Medical Research and Development AMED (21ek0109527s0201, 22ek0109527s0202, 23ek0109527s0203, AMED-CREST, Elucidation of Mechanisms for Stress Responses to Disease Development, and Brain/MINDS from the Japanese Agency for Medical Research and Development) and by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (Grant-in-Aid for Scientific Research on Innovative Areas, Foundation of Synapse and Neurocircuit Pathology, 22110001/22110002).